OTCMKTS:PCHM PharmChem (PCHM) Stock Price, News & Analysis $3.00 0.00 (0.00%) As of 05/2/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartDividendEarningsShort InterestBuy This Stock About PharmChem Stock (OTCMKTS:PCHM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get PharmChem alerts:Sign Up Key Stats Today's Range$3.00▼$3.0050-Day Range$2.97▼$3.4052-Week Range$2.51▼$4.00VolumeN/AAverage Volume6,933 shsMarket Capitalization$13.93 millionP/E Ratio10.33Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewPharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.Read More… PharmChem Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks10th Percentile Overall ScorePCHM MarketRank™: PharmChem scored higher than 10% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for PharmChem. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of PharmChem is 10.33, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 21.97.Price to Earnings Ratio vs. SectorThe P/E ratio of PharmChem is 10.33, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 22.79.Read more about PharmChem's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.01% of the float of PharmChem has been sold short.Short Interest Ratio / Days to CoverPharmChem has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous month Dividend0.0 / 5Dividend StrengthWeak Dividend YieldPharmChem does not currently pay a dividend.Dividend GrowthPharmChem does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of PharmChem is 275.86%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about PharmChem's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.01% of the float of PharmChem has been sold short.Short Interest Ratio / Days to CoverPharmChem has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous month News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for PharmChem this week, compared to 0 articles on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, PharmChem insiders have not sold or bought any company stock.Percentage Held by Insiders17.40% of the stock of PharmChem is held by insiders. A high percentage of insider ownership can be a sign of company health.Read more about PharmChem's insider trading history. Receive PCHM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PharmChem and its competitors with MarketBeat's FREE daily newsletter. Email Address PCHM Stock News HeadlinesPharmChem, Inc. (PCHM) Latest Press Releases & Corporate News - Yahoo FinanceApril 29, 2025 | finance.yahoo.comPharmChem (OTC:PCHM) Stock Quotes, Forecast and News SummaryFebruary 9, 2025 | benzinga.comAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.May 4, 2025 | Paradigm Press (Ad)PharmChem considers strategic alternativesFebruary 3, 2025 | msn.comPharmChem, Inc. Announces Exploration of Strategic AlternativesFebruary 3, 2025 | gurufocus.comPharmChem, Inc. Announces Exploration of Strategic AlternativesFebruary 3, 2025 | prnewswire.comCedar Creek Partners Q3 2024 ResultsOctober 24, 2024 | seekingalpha.comPharmChem, Inc. goes ex dividend tomorrowOctober 9, 2024 | msn.comSee More Headlines PCHM Stock Analysis - Frequently Asked Questions How have PCHM shares performed this year? PharmChem's stock was trading at $3.06 at the start of the year. Since then, PCHM shares have decreased by 2.1% and is now trading at $2.9964. View the best growth stocks for 2025 here. How were PharmChem's earnings last quarter? PharmChem, Inc. (OTCMKTS:PCHM) issued its quarterly earnings data on Thursday, March, 6th. The company reported $0.06 EPS for the quarter. The company earned $1.52 million during the quarter. How do I buy shares of PharmChem? Shares of PCHM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings3/06/2025Today5/04/2025Next Earnings (Estimated)5/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical laboratories Sub-IndustryHealthcare Current SymbolOTCMKTS:PCHM CIKN/A Webwww.pharmchek.com Phone(855) 458-4100Fax817-605-6400Employees170Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.29 Trailing P/E Ratio10.33 Forward P/E RatioN/A P/E GrowthN/ANet Income$850,000.00 Net Margins23.32% Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$6.01 million Price / Sales2.32 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares4,648,000Free Float3,839,000Market Cap$13.93 million OptionableNot Optionable Beta0.64 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (OTCMKTS:PCHM) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PharmChem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PharmChem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.